Elizabeth A Stuart1, Colleen L Barry2, Julie M Donohue3, Shelly F Greenfield4, Kenneth Duckworth5, Zirui Song6, Robert Mechanic7, Elena M Kouri8, Cyrus Ebnesajjad1, Michael E Chernew8, Haiden A Huskamp8. 1. Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MS, USA. 2. Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MS, USA. 3. Department of Health Policy and Management, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA. 4. McLean Hospital, Harvard Medical School, Belmont, MA, USA. 5. Blue Cross Blue Shield of Massachusetts, Boston, MA, USA. 6. Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 7. Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA. 8. Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND AND AIMS: Global payment and accountable care reform efforts in the United States may connect more individuals with substance use disorders (SUD) to treatment. We tested whether such changes instituted under an Alternative Quality Contract (AQC) model within the Blue Cross Blue Shield of Massachusetts' (BCBSMA) insurer increased care for individuals with SUD. DESIGN: Difference-in-differences design comparing enrollees in AQC organizations with a comparison group of enrollees in organizations not participating in the AQC. SETTING: Massachusetts, USA. PARTICIPANTS: BCBSMA enrollees aged 13-64 years from 2006 to 2011 (3 years prior to and after implementation) representing 1 333 534 enrollees and 42 801 SUD service users. MEASUREMENTS: Outcomes were SUD service use and spending and SUD performance metrics. Primary exposures were enrollment into an AQC provider organization and whether the AQC organization did or did not face risk for behavioral health costs. FINDINGS: Enrollees in AQC organizations facing behavioral health risk experienced no change in the probability of using SUD services (1.64 versus 1.66%; P = 0.63), SUD spending ($2807 versus $2700; P = 0.34) or total spending ($12 631 versus $12 849; P = 0.53), or SUD performance metrics (identification: 1.73 versus 1.76%, P = 0.57; initiation: 27.86 versus 27.02%, P = 0.50; engagement: 11.19 versus 10.97%, P = 0.79). Enrollees in AQC organizations not at risk for behavioral health spending experienced a small increase in the probability of using SUD services (1.83 versus 1.66%; P = 0.003) and the identification performance metric (1.92 versus 1.76%; P = 0.007) and a reduction in SUD medication use (11.84 versus 14.03%; P = 0.03) and the initiation performance metric (23.76 versus 27.02%; P = 0.005). CONCLUSIONS: A global payment and accountable care model introduced in Massachusetts, USA (in which a health insurer provided care providers with fixed prepayments to cover most or all of their patients' care during a specified time-period, incentivizing providers to keep their patients healthy and reduce costs) did not lead to sizable changes in substance use disorder service use during the first 3 years following its implementation.
BACKGROUND AND AIMS: Global payment and accountable care reform efforts in the United States may connect more individuals with substance use disorders (SUD) to treatment. We tested whether such changes instituted under an Alternative Quality Contract (AQC) model within the Blue Cross Blue Shield of Massachusetts' (BCBSMA) insurer increased care for individuals with SUD. DESIGN: Difference-in-differences design comparing enrollees in AQC organizations with a comparison group of enrollees in organizations not participating in the AQC. SETTING: Massachusetts, USA. PARTICIPANTS: BCBSMA enrollees aged 13-64 years from 2006 to 2011 (3 years prior to and after implementation) representing 1 333 534 enrollees and 42 801 SUD service users. MEASUREMENTS: Outcomes were SUD service use and spending and SUD performance metrics. Primary exposures were enrollment into an AQC provider organization and whether the AQC organization did or did not face risk for behavioral health costs. FINDINGS: Enrollees in AQC organizations facing behavioral health risk experienced no change in the probability of using SUD services (1.64 versus 1.66%; P = 0.63), SUD spending ($2807 versus $2700; P = 0.34) or total spending ($12 631 versus $12 849; P = 0.53), or SUD performance metrics (identification: 1.73 versus 1.76%, P = 0.57; initiation: 27.86 versus 27.02%, P = 0.50; engagement: 11.19 versus 10.97%, P = 0.79). Enrollees in AQC organizations not at risk for behavioral health spending experienced a small increase in the probability of using SUD services (1.83 versus 1.66%; P = 0.003) and the identification performance metric (1.92 versus 1.76%; P = 0.007) and a reduction in SUD medication use (11.84 versus 14.03%; P = 0.03) and the initiation performance metric (23.76 versus 27.02%; P = 0.005). CONCLUSIONS: A global payment and accountable care model introduced in Massachusetts, USA (in which a health insurer provided care providers with fixed prepayments to cover most or all of their patients' care during a specified time-period, incentivizing providers to keep their patients healthy and reduce costs) did not lead to sizable changes in substance use disorder service use during the first 3 years following its implementation.
Authors: Howard H Goldman; Richard G Frank; M Audrey Burnam; Haiden A Huskamp; M Susan Ridgely; Sharon-Lise T Normand; Alexander S Young; Colleen L Barry; Vanessa Azzone; Alisa B Busch; Susan T Azrin; Garrett Moran; Carolyn Lichtenstein; Margaret Blasinsky Journal: N Engl J Med Date: 2006-03-30 Impact factor: 91.245
Authors: Shelly F Greenfield; Vanessa Azzone; Haiden Huskamp; Brian Cuffel; Thomas Croghan; William Goldman; Richard G Frank Journal: J Subst Abuse Treat Date: 2004-12
Authors: Valerie A Lewis; Carrie H Colla; Katherine Tierney; Arica D Van Citters; Elliott S Fisher; Ellen Meara Journal: Health Aff (Millwood) Date: 2014-10 Impact factor: 6.301
Authors: Christina Andrews; Amanda Abraham; Colleen M Grogan; Harold A Pollack; Clifford Bersamira; Keith Humphreys; Peter Friedmann Journal: Health Aff (Millwood) Date: 2015-05 Impact factor: 6.301
Authors: K John McConnell; Samuel H N Gast; M Susan Ridgely; Neal Wallace; Natalie Jacuzzi; Traci Rieckmann; Bentson H McFarland; Dennis McCarty Journal: Am J Psychiatry Date: 2011-09-02 Impact factor: 18.112
Authors: Colleen L Barry; Elizabeth A Stuart; Julie M Donohue; Shelly F Greenfield; Elena Kouri; Kenneth Duckworth; Zirui Song; Robert E Mechanic; Michael E Chernew; Haiden A Huskamp Journal: Health Aff (Millwood) Date: 2015-12 Impact factor: 6.301
Authors: Gregory C Pope; John Kautter; Randall P Ellis; Arlene S Ash; John Z Ayanian; Lisa I Lezzoni; Melvin J Ingber; Jesse M Levy; John Robst Journal: Health Care Financ Rev Date: 2004
Authors: Julie M Donohue; Colleen L Barry; Elizabeth A Stuart; Shelly F Greenfield; Zirui Song; Michael E Chernew; Haiden A Huskamp Journal: J Addict Med Date: 2018 Jan/Feb Impact factor: 3.702
Authors: Matthew D Eisenberg; Shawn Du; Aditi P Sen; Alene Kennedy-Hendricks; Colleen L Barry Journal: JAMA Psychiatry Date: 2020-08-01 Impact factor: 21.596
Authors: Michal J McDowell; Alisa B Busch; Aditi P Sen; Elizabeth A Stuart; Lauren Riedel; Colleen L Barry; Haiden A Huskamp Journal: Psychiatr Serv Date: 2018-08-28 Impact factor: 3.084
Authors: Emma E McGinty; Howard H Goldman; Bernice A Pescosolido; Colleen L Barry Journal: J Health Polit Policy Law Date: 2018-04-01 Impact factor: 2.265